论文部分内容阅读
目的探讨经导管介入治疗肺动静脉畸形的并发症原因及防治措施。方法对41例(59例次)经导管介入治疗肺动静脉畸形术中及术后14例并发症的患者作回顾性分析,将其分为术中和术后并发症组。结果全组技术成功率94.9%(56例次/59例次),并发症总发生率为35.6%(21/59),其中介入术中发生并发症15.3%(9/59),介入术后发生并发症20.3%(12/59);本组严重并发症发生率仅为1.7%(1/59),无死亡病例。结论经导管介入治疗肺动静脉畸形是一种安全、有效及严重并发症低的非手术方法。
Objective To investigate the causes and prevention and treatment of pulmonary arteriovenous malformations by catheterization. Methods A retrospective analysis was performed on 41 cases (59 cases) of transcatheter interventional therapy of pulmonary arteriovenous malformations and 14 cases of postoperative complications. The patients were divided into intraoperative and postoperative complications. Results The technical success rate of the whole group was 94.9% (56 cases / 59 cases) and the total complication rate was 35.6% (21/59). Interventional complications occurred in 15.3% (9/59) Complications occurred 20.3% (12/59); the incidence of serious complications in this group was only 1.7% (1/59), no deaths. Conclusion Transcatheter interventional treatment of pulmonary arteriovenous malformations is a safe, effective and serious non-surgical method of low complication.